List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #33,171 to #33,220.
- M. smegmatis → Mycobacterium smegmatis
- M. tuberculosis → Mycobacterium tuberculosis
- M. ulcerans → Mycobacterium ulcerans
- M. xenopi → Mycobacterium xenopi
- M.tuberculosis → Mycobacterium tuberculosis
- M1 receptor → Muscarinic acetylcholine receptor M1
- M1 receptors → Muscarinic acetylcholine receptor M1
- M2 receptor → Muscarinic acetylcholine receptor M2
- M2 receptors → Muscarinic acetylcholine receptor M2
- M3 receptor → Muscarinic acetylcholine receptor M3
- M3 receptors → Muscarinic acetylcholine receptor M3
- M5050 → Diprenorphine
- MAC, the Mitochondrial Apoptosis-Induced Channel → Mitochondrial apoptosis-induced channel
- MACH-1 → Mortality Assessment In Congestive Heart Failure Trial
- MADIT → Multicenter automatic defibrillator implantation trial
- MADIT-II → Multicenter Automatic Defibrillator Implantation Trial II
- MAGIC – Presented at AHA 2006 → Myoblast Autologous Grafting In Ischemic Cardiomyopathy
- MAI → Mycobacterium avium intracellulare
- MALDI → Matrix-assisted laser desorption/ionization
- MALDI-TOF → Matrix-assisted laser desorption/ionization
- MALT → MALT lymphoma
- MALT-lymphoma → MALT lymphoma
- MALT-type lymphoma → MALT lymphoma
- MALTOMA → MALT lymphoma
- MALTomas → MALT lymphoma
- MAO → Monoamine oxidase
- MAO-A → Monoamine oxidase
- MAO-B → Monoamine oxidase
- MAOB → Monoamine oxidase B
- MAOI → Monoamine oxidase inhibitor
- MAOIs → Monoamine oxidase inhibitor
- MAO inhibitor → Monoamine oxidase inhibitor
- MAO inhibitors → Monoamine oxidase inhibitor
- MAP → Mean arterial pressure
- MAPK → Mitogen-activated protein kinase
- MAPPET-3 → Management Strategies And Prognosis Of Pulmonary Embolism-3 Trial
- MAP estimator → Maximum a posteriori
- MAP kinase → Mitogen-activated protein kinase
- MAP kinases → Mitogen-activated protein kinase
- MARS → The Monitored Atherosclerosis Regression Study
- MASCOT → Management Of Atrial Fibrillation Suppression In Af-Hf Comorbidity Therapy
- MASH → Mash
- MASP-I → MASP1 (protein)
- MASP-II → MASP2 (protein)
- MASS-II → Second Medicine, Angioplasty, Or Surgery Study
- MASS Syndrome → MASS syndrome
- MAST-E → Thrombolytic Therapy With Streptokinase In Acute Ischemic Stroke
- MASTER → Microvolt T Wave Alternans Testing For Risk Stratification Of Post-Myocardial Infarction Patients
- MAT → Multifocal atrial tachycardia
- MATCH → Management Of Atherothrombosis With Clopidogrel In High-Risk Patients